share_log

Morgan Stanley Initiates Coverage On Ardent Health Partners With Overweight Rating, Announces Price Target of $27

Morgan Stanley Initiates Coverage On Ardent Health Partners With Overweight Rating, Announces Price Target of $27

摩根士丹利开始对Ardent Health Partners进行覆盖,给予超配评级,宣布目标价为27美元。
Benzinga ·  08/12 05:37  · 评级/大行评级

Morgan Stanley analyst Craig Hettenbach initiates coverage on Ardent Health Partners (NYSE:ARDT) with a Overweight rating and announces Price Target of $27.

摩根士丹利分析师Craig Hettenbach开始对Ardent Health Partners (NYSE:ARDT)进行覆盖,给予超额评级,并公布目标价为27美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发